-
Loading metrics
A Virosomal Malaria Peptide Vaccine Elicits a Long-Lasting Sporozoite-Inhibitory Antibody Response in a Phase 1a Clinical Trial
- Shinji L. Okitsu,
- Olivier Silvie,
- Nicole Westerfeld,
- Marija Curcic,
- Andreas R. Kammer,
- Markus S. Mueller,
- Robert W. Sauerwein,
- John A. Robinson,
- Blaise Genton,
- Dominique Mazier
x
- Published: December 5, 2007
- https://doi.org/10.1371/journal.pone.0001278